Janux Therapeutics (JANX) PT Lowered to $38 at Stifel
Tweet Send to a Friend
Stifel analyst Stephen Willey lowered the price target on Janux Therapeutics (NASDAQ: JANX) to $38.00 (from $46.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
